Nano-structures due to their unique properties can provide a biomimetic structure for cell attachment and proliferation in tissue engineering (TE) applications. But sometimes, their surface properties are not particularly suitable for directed tissue growth. In this regard, present study has focused on fabrication and hydrolysis of Poly (ε-caprolactone) (PCL)/Polyurethane (PU) by aqueous sodium hydroxide (NaOH) with a view to modify the surface and hydrophilicity of the structures. The characterizations and mechanical properties of non-hydrolyzed and hydrolyzed nano-structures were evaluated by SEM, FESEM, FTIR, water contact angle and tensile stress. The all hydrolyzed nano-structures showed improvement in contact angle after 2h at all concentrations of NaOH. The PCL, PU, PCL75%:PU25%, and PCL25%:PU75% structures have shown 3.8%, 12.5%, 4.1% and 7%, respectively, of shrinkage at hydrolysis at 3 M NaOH and 3 h. The PCL25%:PU75% structure indicated the greatest reduction in stress and strain at 3 M NaOH and 3 h (1.1 ± 0.06 MPa with 52% decreases) and (156 ± 5% with 49% decreases), respectively. Also, the structure with 75% of PCL showed 28% reduction in Young's Modulus (4.33 ± 0.45 MPa) at 3 M NaOH after 2 h. It is noted that the hydrolysis treatment with 3 M of NaOH concentration at 2 h is optimum condition for hydrolysis hybrid nan-structures for TE applications. Also, the results of this study proposed that hydrolyzed PCL75%:PU25% hybrid nano-structures due to its unique mechanical properties and optimum surface modification could be promising candidate for TE applications.
The main objective of the present review article is to investigate the in-vitro and in-vivo biocompatibility behavior of hybrid PCL-based scaffolds with collagen, gelatin, and chitosan to improve endothelialization for VTE applications. It is reported that the high-rate failure of small diameters vascular grafts (SDVGs, <6 mm) due to adhesion of platelets and plasma protein and aggregation, over-proliferation of smooth muscle cells (SMCs), and neointimal hyperplasia at the implantation site is main challenge in vascular tissue engineering (VTE). The fast re-establishment of a functional endothelial cell (EC) layer representing a crucial importance strategy has been proposed to reduce these adverse outcomes. Polycaprolactone (PCL), with optimum mechanical properties, it showed great potential in biomedical applications, but its biocompatibility is still highly concerned in VTE. Modifications of the PCL vascular grafts by developing the hybrid structures using natural polymers with optimum hydrophilicity and biocompatibility properties in order to speed up the re-endothelialization process have been proposed over the last years. Analyzing the mentioned results in the present study can offer a better understanding of the benefits and challenges of applying the natural polymer as a thrombotic response upon implantation in clinical trials. Also, it can suggest the PCL-Collagen as the best framework for the fabrication of rationally designed SDVGs for VTE.
Acne is an inflammatory disease of the sebaceous glands. Melittin (Mel) is one of the principal toxic components of bee venom that can cause antibacterial and anti-inflammatory effects. Chitosan is a biodegradable polysaccharide has anti-inflammatory, antimicrobial, and regenerative properties. In this study, chitosan (Ch)/Mel 0.001 and 0.003% nanofibers were fabricated for topical treatment of acne vulgaris. Physicochemical properties of Ch/Mel were evaluated using FTIR and FESEM. Furthermore, encapsulation efficiency, tensile strength, water absorption capacity, enzymatic activity, drug release, antimicrobial, and cell cytotoxicity were assayed. Animal models were exerted to study the impact of Ch/Mel nanofibers on the treatment of Propionibacterium acnes. The FESEM results showed that nanofibers were successfully prepared in nano-scale fiber diameter. The FTIR confirmed the presence of Mel in structures. The addition of melittin to the polymer solution reduced electrical conductivity, induced viscosity and tensile strength of the fibers, and decreased the percentage of the swelling. The Mel loading into Ch/Mel 0.003% was reported at 86.74±1%. This Mel releasing process (89.65%) of Ch/Mel 0.003% was slowly completed during 72 h. The Mel retained its hemolytic activity after being loaded into the polymer structure. The drug toxicity study displayed the lack of any significant toxicity from Ch/Mel nanofibers on normal Human Dermal Fibroblasts (HDF). The Ch/Mel 0.003% achieved the highest growth inhibition in P. acnes in vitro and animal studies, this group showed the greatest reduction in inflammation and redness. The Ch/Mel 0.003% structure is proposed as a suitable topical drug delivery system for treating acne vulgaris.